从而证实肾骨胶囊是一种纠正血透患者钙磷代谢紊乱的有效药物。
Shengu capsule is effective to correct the calcium and phosphorus metabolism disorder in hemodialysis patients.
目的通过对目前腹膜透析患者钙磷代谢情况进行调查，以期发现钙磷代谢紊乱的发生原因和促进因素。
Objectve By investigated the calcium and phosphorus metabolism in peritoneal dialysis patients, to determined its causing and promoting factors.
目的：评价低钙透析液和含钙的磷结合剂治疗对终末期肾病腹膜透析患者钙磷代谢紊乱和冠状动脉钙化进展的影响。
Objective: to evaluate the effect of low-calcium peritoneal dialysate and phosphate binder on calcium and phosphate abnormality and coronary artery calcification of end-stage renal disease patients.
目的探讨血液透析(HD)对慢性肾功衰竭(CRF)病人钙磷代谢紊乱及继发甲状旁腺功能亢进(SHPT)的作用。
Objective To investigate the effects of hemodialysis (HD) on the disorders of calcium phosphate metabolism and secondary hyperparathyroidism (SHPT) in patients with chronic renal failure (CRF).
目的探讨血液透析(HD)对慢性肾功衰竭(CRF)病人钙磷代谢紊乱及继发甲状旁腺功能亢进(SHPT)的作用。
Objective To investigate the effects of hemodialysis (HD) on the disorders of calcium phosphate metabolism and secondary hyperparathyroidism (SHPT) in patients with chronic renal failure (CRF).
应用推荐